Avalyn Pharma Inc. Common Stock
AVLN
Rank in Stocks
#7536
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Share Price
$27.92
Last synced: 2026-11-17
Market Cap
$1.24B
Change (1 day)
-6.18%
Change (1 year)
-
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Avalyn Pharma Inc. Common Stock (AVLN)
Category
Healthcare
EPS for Avalyn Pharma Inc. Common Stock (AVLN)
EPS as of September 2026 TTM: $-2.53
According to Avalyn Pharma Inc. Common Stock's latest financial reports, its current EPS (TTM) is $-2.53. At the end of 2026 the company had an EPS of 0, equal to its 2026 EPS of 0.
EPS history for Avalyn Pharma Inc. Common Stock from 2025 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.53 | 24.02% |
| 2025 | $-2.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -718.97% |
US
|
|
| $-7.08 | 179.84% |
US
|
|
| $-5.29 | 109.09% |
AU
|
|
| $21.56 | -952.17% |
NL
|
|
| $12.73 | -603.25% |
BE
|
Questions about Avalyn Pharma Inc. Common Stock's earnings per share (EPS)
What is Avalyn Pharma Inc. Common Stock's earnings per share (EPS)?
Avalyn Pharma Inc. Common Stock's earnings per share (EPS) over the last twelve months is $-2.53, as of Sep 2026.
How does Avalyn Pharma Inc. Common Stock's earnings per share (EPS) compare with similar companies?
Avalyn Pharma Inc. Common Stock's earnings per share (EPS) ($-2.53) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.